Page 54 - 1

54
Goldstein, A.; Tachibana, S.; Lowney, L.I.; Hunkapiller M. and
Hood, L. Dynorphin-(1-13), an extraordinary potent opioid peptide.
Proceedings of the National Academy of Science USA 1979 76: 6666-
6670.

Hughes, J. Isolation of an endogenous compound from the brain with
properties similar to morphine. Brain Research 1975 (a), 88: 295-308

Kosten TR, George TP. The neurobiology of opioid dependence:
implications for treatment. Science & Practice Perspectives.
2002;1(1):13-20.

Leshner, A.I. Addiction is a brain disease, and it matters. Science
278:45-47. 1997.

Nestler, EJ, Malenka RC. The addicted brain. Scientific American.
March 2004.

NIH (National Institutes of Health). Effective Medical Treatment of
Opiate Addiction. NIH Consensus Statement. Bethesda, MD: National
Institutes of Health; 1997 (Nov 17-19);15(6):1-38. (See also: JAMA.
1998;280:1936-1943.)

Payte JT, Zweben JE, Martin J. Opioid maintenance treatment. In:
Graham AW, Schultz TK, Mayo-Smith MF, Ries RK, Wilford BB.
Principles of Addiction Medicine. Chevy Chase, MD: American
Society of Addiction Medicine; 2003: 751-766.

Woods, J. How methadone works. National Alliance of Methadone
Advocates. 2003